Wofer-XT Injection contains Iron Sucrose (20mg/ml), a parenteral iron preparation indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease (CKD) and other conditions where oral iron therapy is ineffective or contraindicated. Iron Sucrose is a complex of polynuclear iron(III)-hydroxide in sucrose, designed to replenish iron stores by providing bioavailable iron essential for hemoglobin synthesis and erythropoiesis. The injection is administered intravenously, allowing rapid correction of iron deficiency with a favorable safety profile compared to older iron formulations. Wofer-XT Injection is particularly useful in patients undergoing hemodialysis or those receiving erythropoiesis-stimulating agents (ESAs) to optimize hemoglobin response. Dosage and administration should be individualized based on the patient’s iron requirements, hemoglobin levels, and clinical status, with careful monitoring to avoid iron overload. Common adverse reactions may include transient hypotension, nausea, headache, and injection site reactions. Hypersensitivity reactions, although rare, necessitate immediate discontinuation and appropriate medical intervention. Wofer-XT Injection should be used under strict medical supervision, ensuring appropriate patient selection and adherence to recommended dosing protocols to achieve effective and safe management of iron deficiency anemia.